Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast Cancer
This trial is active, not recruiting.
|Treatment||adriamycin, taxol and cytoxan|
|Sponsor||King Faisal Specialist Hospital & Research Center|
|Start date||September 2007|
|End date||September 2012|
|Trial size||100 participants|
|Trial identifier||NCT00538395, RAC #981-020|
Intensive sequential chemotherapy with Adriamycin Taxol and Cytoxan in the treatment of locally advanced breast cancer
|Intervention model||single group assignment|
time frame: overall
Male or female participants of any age.
Inclusion Criteria: - Patients with locally advanced breast cancer
|Principal investigator||Adnan Ezzat, MD|
Call for more information